Navigation Links
Drug dosages often incorrect for obese patients

PORTLAND, Ore. As if severely overweight people didnt already have enough health concerns, experts are raising another red flag the possibility that some of their prescription medications, especially antibiotics, may not be prescribed at the appropriate dosage and could be ineffective.

Because most adult antibiotics are produced in a one size fits all dosage and some doctors are not attuned to this issue, the societal trend towards severe obesity is resulting in more individuals who get inappropriate drug therapies for infectious disease, a new study in the journal Pharmacotherapy suggests.

The number of individuals with the highest body mass index, very obese people, is up 600 percent between 1986 and 2000, said David Bearden, a clinical associate professor in the College of Pharmacy at Oregon State University.

Very obese individuals in some cases, even those with severe infections, may be getting only half the necessary dose of a prescription drug such as an antibiotic, Bearden said. Thats a problem. It could lead not only to antibiotic failure but also an increase in antibiotic resistance, another serious issue.

The problem is somewhat less of a concern with dosages of medications that patients take for extended periods, such as blood pressure or cholesterol medications, because the results of taking those medications are more routinely monitored and dosages can be increased as necessary. Its a particular concern with antibiotics, Bearden said, because they are often used to treat severe or even life-threatening infections, and bad things can happen quickly if the drug is ineffective.

Drug companies are just now becoming more aware of this issue and beginning to test and recommend dosages more appropriate for adults of varying weights, Bearden said. But with older drugs that are commonly used, there often is very little or no data for adjusting dosages. In actual practice the issue is often ignored outright, or educated guesses are made with whatever data is available.

Without more attention, the issue may only get worse, and its not just a U.S. phenomenon. The World Health Organization estimates that 400 million people were obese in 2005 and that the total will increase to 700 million by 2015. It considers these numbers a global pandemic that is affecting low, middle and high-income nations around the world. Obesity is also considered an independent risk factor for surgical site infections and is associated with higher mortality rates in critically ill patients.

Even if the problem is carefully considered, Bearden said, its not simple.

It would be nice if we could just use a simple multiplier to adjust drug dosages for overweight people, Bearden said. But its not that easy. There are a lot of factors that affect drug distribution in the body, including age, weight, kidney function, other disease problems and the type of antibiotic or other drug.

Adipose tissue, or body fat, affects how the human body interacts with drugs. With some drugs it absorbs large amounts of a prescription medication, but with others, it doesnt. And sometimes there is a very fine line between a drug being effective at one dose, ineffective if the dose is too low, and toxic if its too high. All of these issues affect appropriate dosages, and in many situations, the data needed to evaluate the problem simply doesnt exist.

The issue of adjusted drug dosages has been known and addressed in children for decades, experts say, because of the obvious distinction between a 30-pound toddler and a 120-pound youngster. But with adults, far less attention has been given the problem. The medical and pharmaceutical industries often just assume that everyone weighs about 150-170 pounds.

This is enough of an issue that if I were a very obese person being given an antibiotic, I would discuss it with my doctor, Bearden said. Hopefully the doctor will already have considered it and will be able to address your concerns. If not, then its a conversation you need to have, and more medical specialists, including pharmacists, may need to be consulted.


Contact: David Bearden
Oregon State University

Related biology news :

1. Claims of sex-related differences in genetic association studies often not properly validated
2. Why conservation efforts often fail
3. Studies: Children obese due to a host of unhealthy pressures
4. Abnormal fat metabolism underlies heart problems in diabetic patients
5. A new radiation therapy treatment developed for head and neck cancer patients
6. Device helps patients survive, regain function til transplant
7. Diet support helps chronic kidney patients
8. Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials
9. Doctors learn to control their own brains pain responses to better treat patients
10. Jefferson urologists studying regenerated neo-bladder to help spinal cord injury patients
11. Israeli scientists identify: Genes that affect responses of multiple sclerosis patients to copaxone
Post Your Comments:
(Date:11/18/2015)... 18, 2015 --> ... new market report titled  Gesture Recognition Market - Global ... - 2021. According to the report, the global gesture recognition market was ... to reach US$29.1 bn by 2021, at a CAGR ... North America dominated the global gesture recognition ...
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... 10, 2015  In this report, the ... of product, type, application, disease indication, and ... report are consumables, services, software. The type ... biomarkers, efficacy biomarkers, and validation biomarkers. The ... diagnostics development, drug discovery and development, personalized ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... and NEW YORK , November 24, ... investment by Bristol-Myers Squibb in a European ... Bristol-Myers Squibb Company in which the companies will work ... immuno-oncology and other areas of unmet medical need. The collaboration ... LSP 5, the latest LSP fund. This is the first ...
(Date:11/24/2015)... , Nov. 24, 2015 According to two new ... 2005. This is something that many doctors, scientists, and public ... questions remains: with fewer PSA tests being done, will there ... Dr. David Samadi, "Despite the efforts made ... remains the second leading cancer cause of death in men, ...
(Date:11/23/2015)... Nov. 23, 2015   Ceres, Inc . (Nasdaq: ... financial results for the fiscal year ended August 31, ... --> --> During fiscal ... and feed products with a better balance of yield, ... distribution agreements with several leading crop input providers and ...
(Date:11/23/2015)... Md. (PRWEB) , ... November 23, 2015 , ... ... 100 award for the development of its Nexera UC Unified Chromatography system. The ... 100 most technically significant new products of the year in the analytical and ...
Breaking Biology Technology: